Select Bibliography

Filter by any of these (after searching):

AUTHOR ABSTRACT DEADLINES

A meeting abstract must be submitted by the first or corresponding author to the Alliance Publications Coordinator (publications@AllianceNCTN.org) at least two weeks prior to the meeting abstract submission deadline. For detailed information about Alliance Publications guidelines, please refer to the policies, along with the author abstract deadlines.

There are 4 items

A North Central Cancer Treatment Group (NCCTG) Phase II Trial of VEGF Trap in Patients With Metastatic Breast Cancer (MBC) Previously Treated with an Anthracycline and/or a Taxane.

Hobday, T. , Rowland, K., Jr , Dueck, A. , Northfelt, D. , Lingle, W. ... - ASCO Breast - Breast Cancer Symposium - 2008

Abstract - Primary - Primary - Breast - NCCTG-N0537

Intrinsic subtype and response to paclitaxel in CALGB 9344 tissue microarrays

Nielsen, T. O. , Jewell, S. D. , Thor, A. D. , Gao, D. , Perou, C. M. ... - ASCO Breast - Breast Cancer Symposium - 2009

Abstract - Secondary - Primary - Correl Sci NOS - CALGB-159905 , CALGB-9344

ACOSOG Z1031: A randomized phase II trial comparing exemestane, letrozole and anastrozole in postmenopausal women with clinical stage II/III estrogen receptor positive breast cancer

Olson, J. A., Jr , Babiera, G. V. , Unzeitig, G. , Marcom, P. K. ... - ASCO Breast - Breast Cancer Symposium - 2010

Abstract - Primary - Primary - Breast - ACOSOG-Z1031

Age, Race, BMI and Pathologic Complete Response Following Neoadjuvant Chemotherapy: An Analysis of Four Alliance Clinical Trials

Warner, Erica T. , Ballman, Karla V. , Strand, Carrie ... - ASCO Breast - J Clin Oncol - 2015

Abstract - Primary - Primary - Disparities - Alliance-A151426 , ACOSOG-Z1031 , ACOSOG-Z1041 , CALGB-40601 , CALGB-40603